id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0936-0007,FDA,FDA-2022-E-0936,Interim Extension Letter,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:50:03Z,,0,0,09000064863e62e2
FDA-2022-E-0936-0008,FDA,FDA-2022-E-0936,Letter from U.S. Patent and Trademark Office to McCarter & English LLP,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:50:18Z,,0,0,090000648661359d
FDA-2022-E-0936-0009,FDA,FDA-2022-E-0936,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T20:50:27Z,,0,0,0900006486613a70
FDA-2022-E-0936-0006,FDA,FDA-2022-E-0936,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2024-01-19T05:00:00Z,2024,1,2024-01-19T05:00:00Z,,2024-01-19T21:48:32Z,,0,0,09000064863ae6f0